All News-API(Active Pharmaceutical Ingredients),Pharmaceutical Excipients, Pharmaceutical Intermediates, Plant Extract and Nutritional Products.
Ciclopirox Olamine demand is increasing 2012-01-06

With environmental pollution, skin diseases are also increasing. Especially in hot weather of undeveloped and developing countries, the situation is more serious. Personal hygiene and sanitation is one of the important reasons of infecting skin diseases.

Fungal skin disease is one of the most common skin disease. Ciclopirox Olamine, with its excellent antifungal treatment of the dermatological infections tinea pedis, tinea cruris, tinea corporis, candidiasis(moniliasis) and tinea(pityriasis) vesicolor, the demand is increasing gradually.

CPhI 2012 2012-02-18

CPhI Japan 2012  
21-23 March, 2012 at Big Sight Exhibition Centre, Tokyo, Japan

CPhI China 2012   
26-28 June, 2012  at SNIEC, Shanghai, China

CPhI South America 2012  
21-23 August, 2012  at Sao Paulo, Brazil

CPhI Worldwide 2012
9-11 October, 2012 at Feria de Madrid, Spain

CPhI India 2012
21-23 November, 2012 at Bombay Exibition Centre, Mumbai, India

Turkey Pharmaceutical Market 2012-02-21

Turkey has a population of 72.6 million people. Turkey is the world's 12th largest pharmaceutical market. Turkish pharmaceutical market growth has been keeping more than 10% each year.

There’re more than 300 pharmaceutical companies, 95% of them are foreign capital companies. And the top 6 pharmaceutical companies covers 90% of the market share.

60% of Turkey drugs relies on imports. All the imported drugs must be registered first. Turkey don’t have its own GMP standard but adopts European GMP standard. For the 40% of local production drugs, 95% of it is produced by the joint venture pharmaceutical production. Due to expensive cost of drugs, Turkey government encourage to use generic drugs.

Turkey is also a re-export country. Their main exports countries is European Union, Russia and CIS countries.

Columbia transfers progesterone vaginal gel NDA 2012-02-22
Singapore and EU bilateral free trade agreement negotiations successfully 2013-01-08
APIs from China and India - will Import go down in 2013? 2013-01-12
India, China plan to jointly oppose EU regulation on API at WTO forum 2013-01-12
China maintains position as API resource for India 2013-01-17
Africa pays more than Asia and Europe for key antibiotic ciprofloxacin 2013-01-17
China now one of the world's largest heparin API producers and exporters 2013-01-17
Market Research Projects API Market Growth at 7.9% CAGR Through 2016 2013-02-22
Good Distribution Practices for APIs - EU Commission Publishes Draft Guideline 2013-02-27
Revenue Growth Optimism in Pharmaceutical Industry: 2013 Survey Reports at 2013-02-27
Africa becomes largest Chinese medicine export market 2013-02-27
SFDA asks API makers for GMP certificates ahead of new EU import laws 2013-03-07
Non-EU regulators can use EMA/FDA data for API export letters 2013-03-07
US asks for exemption from EU API import laws 2013-03-07
MHRA says 1,200 API plants may need inspecting under new import laws 2013-03-07
EDQM restricts the Acceptance of Substances for New CEP Applications 2013-03-07
Plant Extracts May Help Cure Breast Cancer 2013-04-18
News about GMP/cGMP: CFDA Relevant issues on Written Confirmation 2013-11-27
Plant Extracts May Help Floppy Baby Syndrome 2014-01-03
FDA alerts companies to stop illegal sale of treatments for diabetes 2014-03-21
Pharmaceutical Companies to Tap Opportunities in Emerging Markets 2014-04-04
Eyes On Excipients-Inactive but essential drug ingredients are getting checked out with modern rigor to ensure their quality 2014-04-09
2015 CPhI 2014-12-27
USP Advocates for the Use of Pharmacopeial Standards and Regulatory Compliance at CPhI China 2015 2015-06-26